Baird Downgrades Homology Medicines (FIXX) to Neutral

July 28, 2023 2:26 AM EDT Send to a Friend
(Updated - July 28, 2023 6:24 AM EDT)

Baird analyst Jack Allen downgraded Homology Medicines (NASDAQ: FIXX) from Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login